常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.73/-1.34
|
|
企業價值
42.01M
|
| 資產負債 |
|
每股賬面淨值
2.07
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
14.97M
|
|
每股收益
0.33
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2025/11/16 02:44 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines. |

0.795 
